Wyatt Technology has announced the release of a novel method suitable for determining multiple critical quality attributes of adeno-associated virus and similar small gene vectors, in a single chromatographic run.

MagSi-NA Pathogens Kit from AMSBIO are designed to enable easy extraction of DNA and RNA from serum, plasma, oropharyngeal swab/nasopharyngeal swab, and any other respiratory samples for pathogen detection.

Avacta has entered into a collaboration with Cytiva to develop and manufacture a point-of-care rapid test intended for screening of large populations to diagnose the COVID-19 coronavirus infection.

ProCulture® is designed to cover multiple steps of the cell culture process from isolation to harvesting.

DNAfit has made its at-home exercise platform, in which individuals only have to do specific exercises relevant to their genetics, free.

Oxford Gene Technology has announced the addition of accurate detection capabilities for translocations and difficult-to-sequence partial tandem duplications (PTDs) in its myPanel™ customizable SureSeq™ NGS panels.

Metrion Biosciences has contributed to two new papers that focus on the application of improved cardiac safety testing protocols and recommendations for best practice for the drug discovery industry.

In response to the global COVID-19 pandemic, Beckman Coulter has announced that it is developing assays to identify IgM and IgG antibodies to SARS-CoV-2.

Zegami has developed a new machine learning model using x-rays of COVID-19 infected lungs, artificial intelligence techniques and data visualization tools that could help medical professionals identify coronavirus cases more effectively.

Horizon Discovery has announced the addition of an arrayed CRISPR knockout screening service for primary human B cells to its cell-based screening services.